Different Effects of Simvastatin and Losartan on Cytokine Levels in Coronary Artery Disease

By Sadamatsu Kenji  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 3, 2006-01 ,pp. : 169-175

Adis International

Access to resources Recommend Favorite

Losartan and enalapril therapies enhance vasodilatation in the mesenteric artery of spontaneously hypertensive rats

By Kahonen M.   Tolvanen J.-P.   Kalliovalkama J.   Wu X.   Karjala K.   Makynen H.   Porsti I.  

European Journal of Pharmacology, Vol. 368, Iss. 2, 1999-03 ,pp. : 213-222

Elsevier

Access to resources Recommend Favorite

Angiotensin II-Receptor Antagonist Losartan Does not Prevent Nitroglycerin Tolerance in Patients with Coronary Artery Disease

By Longobardi Giancarlo   Ferrara Nicola   Leosco Dario   Abete Pasquale   Furgi Giuseppe   Cacciatore Francesco   Corbi Graziamaria   Pescatore Raffaella   Rengo Franco  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 5, 2004-09 ,pp. : 363-370

Springer Publishing Company

Access to resources Recommend Favorite

Both enalapril and losartan attenuate sarcolemmal Na⁺-K⁺-ATPase remodeling in failing rat heart due to myocardial infarction

By Guo Xiaobing   Wang Jingwei   Elimban Vijayan   Dhalla Naranjan S.  

Canadian Journal of Physiology and Pharmacology, Vol. 86, Iss. 4, 2008-04 ,pp. : 139-147

NRC Research Press

Access to resources Recommend Favorite

The potential of mipomersen, an ApoB synthesis inhibitor, to reduce necessity for LDL-apheresis in patients with heterozygous familial hypercholesterolemia and coronary artery disease

By Vogt Anja   Parhofer Klaus G  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 6, 2013-04 ,pp. : 691-697

Informa Healthcare

Access to resources Recommend Favorite